{"id":"https://openalex.org/W1978465583","doi":"https://doi.org/10.1038/sj.leu.2404023","title":"Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting shingosine kinase-1","display_name":"Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting shingosine kinase-1","publication_year":2005,"publication_date":"2005-11-10","ids":{"openalex":"https://openalex.org/W1978465583","doi":"https://doi.org/10.1038/sj.leu.2404023","mag":"1978465583","pmid":"https://pubmed.ncbi.nlm.nih.gov/16281067"},"language":"en","primary_location":{"id":"doi:10.1038/sj.leu.2404023","doi":"https://doi.org/10.1038/sj.leu.2404023","is_oa":false,"landing_page_url":"https://doi.org/10.1038/sj.leu.2404023","pdf_url":null,"source":{"id":"https://openalex.org/S149476849","display_name":"Leukemia","issn_l":"0887-6924","issn":["0887-6924","1476-5551"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024105408","display_name":"Elisabeth Bonhoure","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"E Bonhoure","raw_affiliation_strings":["Inserm, U466, Toulouse F-31432, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inserm, U466, Toulouse F-31432, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025314043","display_name":"Dmitri Pchejetski","orcid":"https://orcid.org/0000-0003-1074-9261","observed_orcids":["https://orcid.org/0000-0003-1074-9261"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"D Pchejetski","raw_affiliation_strings":["Inserm, U466, Toulouse, F-31432, France","Inserm, U466, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inserm, U466, Toulouse, F-31432, France","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"Inserm, U466, Toulouse, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111556294","display_name":"Nass\u00e9ra Aouali","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]},{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I96226040","display_name":"Universit\u00e9 de Reims Champagne-Ardenne","ror":"https://ror.org/03hypw319","country_code":"FR","type":"education","lineage":["https://openalex.org/I96226040"]}],"countries":["FR","US"],"is_corresponding":false,"raw_author_name":"N Aouali","raw_affiliation_strings":["CNRS, UMR 6142, Reims, F-51096, France","Universit\u00e9 de Reims Champagne-Ardennes, UFR de Pharmacie, IFR33, Reims, F-51096, France","CNRS, UMR 6142, Reims, France","Department of Cancer Genetics, Roswell Park Center Institute, Buffalo, USA","Universit\u00e9 de Reims Champagne-Ardennes, UFR de Pharmacie, IFR33, Reims, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CNRS, UMR 6142, Reims, F-51096, France","institution_ids":["https://openalex.org/I1294671590"]},{"raw_affiliation_string":"Universit\u00e9 de Reims Champagne-Ardennes, UFR de Pharmacie, IFR33, Reims, F-51096, France","institution_ids":["https://openalex.org/I96226040"]},{"raw_affiliation_string":"CNRS, UMR 6142, Reims, France","institution_ids":["https://openalex.org/I1294671590"]},{"raw_affiliation_string":"Department of Cancer Genetics, Roswell Park Center Institute, Buffalo, USA","institution_ids":["https://openalex.org/I1292894508"]},{"raw_affiliation_string":"Universit\u00e9 de Reims Champagne-Ardennes, UFR de Pharmacie, IFR33, Reims, France","institution_ids":["https://openalex.org/I96226040"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059253619","display_name":"Hamid Morjani","orcid":"https://orcid.org/0000-0003-1959-7807","observed_orcids":["https://orcid.org/0000-0003-1959-7807"]},"institutions":[{"id":"https://openalex.org/I96226040","display_name":"Universit\u00e9 de Reims Champagne-Ardenne","ror":"https://ror.org/03hypw319","country_code":"FR","type":"education","lineage":["https://openalex.org/I96226040"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"H Morjani","raw_affiliation_strings":["Universit\u00e9 de Reims Champagne-Andrennes, UFR de Pharmacie, IFR33, JE2428 Onco-Pharamcologie, Reims, F-51096, France","Universit\u00e9 de Reims Champagne-Andrennes, UFR de Pharmacie, IFR33, JE2428 Onco-Pharamcologie, Reims, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e9 de Reims Champagne-Andrennes, UFR de Pharmacie, IFR33, JE2428 Onco-Pharamcologie, Reims, F-51096, France","institution_ids":["https://openalex.org/I96226040"]},{"raw_affiliation_string":"Universit\u00e9 de Reims Champagne-Andrennes, UFR de Pharmacie, IFR33, JE2428 Onco-Pharamcologie, Reims, France","institution_ids":["https://openalex.org/I96226040"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073545182","display_name":"Thierry Levade","orcid":"https://orcid.org/0000-0003-3793-2584","observed_orcids":["https://orcid.org/0000-0003-3793-2584"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"T Levade","raw_affiliation_strings":["Inserm, U466, Toulouse, F-31432, France","Inserm, U466, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inserm, U466, Toulouse, F-31432, France","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"Inserm, U466, Toulouse, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006381064","display_name":"Takafumi Kohama","orcid":"https://orcid.org/0000-0002-6822-8170","observed_orcids":["https://orcid.org/0000-0002-6822-8170"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T Kohama","raw_affiliation_strings":["Sankyo Co. Ltd, Pharmacology and Molecular Biology Research Laboratories, Research Group I, Tokyo, 140-8710, Japan","Sankyo Co. Ltd, Pharmacology and Molecular Biology Research Laboratories, Research Group I, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sankyo Co. Ltd, Pharmacology and Molecular Biology Research Laboratories, Research Group I, Tokyo, 140-8710, Japan","institution_ids":[]},{"raw_affiliation_string":"Sankyo Co. Ltd, Pharmacology and Molecular Biology Research Laboratories, Research Group I, Tokyo, Japan","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009584708","display_name":"Olivier Cuvillier","orcid":"https://orcid.org/0000-0003-3346-375X","observed_orcids":["https://orcid.org/0000-0003-3346-375X"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"O Cuvillier","raw_affiliation_strings":["Inserm, U466, Toulouse, F-31432, France","Inserm, U466, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inserm, U466, Toulouse, F-31432, France","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"Inserm, U466, Toulouse, France","institution_ids":["https://openalex.org/I154526488"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5009584708"],"corresponding_institution_ids":["https://openalex.org/I154526488"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":null,"fwci":3.3038,"has_fulltext":false,"cited_by_count":176,"citation_normalized_percentile":{"value":0.93114186,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":99},"biblio":{"volume":"20","issue":"1","first_page":"95","last_page":"102"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11308","display_name":"Sphingolipid Metabolism and Signaling","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11308","display_name":"Sphingolipid Metabolism and Signaling","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sphingosine-kinase-1","display_name":"sphingosine kinase 1","score":0.9760000109672546},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.8429999947547913},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9800000190734863},{"id":"https://openalex.org/keywords/hl-60-cells","display_name":"HL-60 cells","score":0.9810000061988831},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.8830000162124634},{"id":"https://openalex.org/keywords/ceramide","display_name":"ceramide","score":0.7279999852180481},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.7409999966621399},{"id":"https://openalex.org/keywords/cytochrome-c-release","display_name":"cytochrome c release","score":0.7609999775886536},{"id":"https://openalex.org/keywords/mrp1","display_name":"MRP1","score":0.718999981880188},{"id":"https://openalex.org/keywords/mdr1","display_name":"MDR1","score":0.8619999885559082},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.7900000214576721},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":0.9929999709129333},{"id":"https://openalex.org/keywords/sphingosine-1-phosphate","display_name":"sphingosine-1-phosphate","score":0.9419999718666077},{"id":"https://openalex.org/keywords/xiap","display_name":"XIAP","score":0.9490000009536743},{"id":"https://openalex.org/keywords/smac","display_name":"Smac/DIABLO","score":0.8889999985694885},{"id":"https://openalex.org/keywords/caspase-3","display_name":"caspase-3","score":0.9459999799728394}],"concepts":[{"id":"https://openalex.org/C2778703144","wikidata":"https://www.wikidata.org/wiki/Q46298","display_name":"Sphingosine","level":3,"score":0.8430597186088562},{"id":"https://openalex.org/C2777700496","wikidata":"https://www.wikidata.org/wiki/Q7576797","display_name":"Sphingosine kinase","level":5,"score":0.8290908932685852},{"id":"https://openalex.org/C2777851122","wikidata":"https://www.wikidata.org/wiki/Q424213","display_name":"Ceramide","level":3,"score":0.7454000115394592},{"id":"https://openalex.org/C61705674","wikidata":"https://www.wikidata.org/wiki/Q410395","display_name":"Sphingolipid","level":2,"score":0.6475958228111267},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5841977596282959},{"id":"https://openalex.org/C2777550365","wikidata":"https://www.wikidata.org/wiki/Q14913834","display_name":"Sphingosine kinase 1","level":5,"score":0.5675137042999268},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.5661846399307251},{"id":"https://openalex.org/C180899940","wikidata":"https://www.wikidata.org/wiki/Q117982","display_name":"Lipid signaling","level":3,"score":0.5425747632980347},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4838225245475769},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.464680939912796},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.4201260209083557},{"id":"https://openalex.org/C2776596873","wikidata":"https://www.wikidata.org/wiki/Q418267","display_name":"Sphingosine-1-phosphate","level":4,"score":0.412982314825058},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3809107542037964},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.23238465189933777},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0643969178199768},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.046305060386657715}],"mesh":[{"descriptor_ui":"D000099157","descriptor_name":"Sphingosine Kinase","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000208","descriptor_name":"Acute Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002518","descriptor_name":"Ceramides","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007951","descriptor_name":"Leukemia, Myeloid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D007951","descriptor_name":"Leukemia, Myeloid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008928","descriptor_name":"Mitochondria","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016227","descriptor_name":"Benzoquinones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017853","descriptor_name":"Phosphotransferases (Alcohol Group Acceptor)","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D017853","descriptor_name":"Phosphotransferases (Alcohol Group Acceptor)","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017853","descriptor_name":"Phosphotransferases (Alcohol Group Acceptor)","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018432","descriptor_name":"Drug Resistance, Multiple","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018922","descriptor_name":"HL-60 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D034622","descriptor_name":"RNA Interference","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049349","descriptor_name":"Receptors, Lysosphingolipid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1038/sj.leu.2404023","doi":"https://doi.org/10.1038/sj.leu.2404023","is_oa":false,"landing_page_url":"https://doi.org/10.1038/sj.leu.2404023","pdf_url":null,"source":{"id":"https://openalex.org/S149476849","display_name":"Leukemia","issn_l":"0887-6924","issn":["0887-6924","1476-5551"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia","raw_type":"journal-article"},{"id":"pmid:16281067","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16281067","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia","raw_type":"Journal Article"},{"id":"pmh:oai:ueaeprints.uea.ac.uk:51545","doi":null,"is_oa":false,"landing_page_url":"https://ueaeprints.uea.ac.uk/id/eprint/51545/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400384","display_name":"UEA Digital Repository (University of East Anglia)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1118541","host_organization_name":"University of East Anglia","host_organization_lineage":["https://openalex.org/I1118541"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320309383","display_name":"Medical University of South Carolina","ror":"https://ror.org/012jban78"},{"id":"https://openalex.org/F4320322363","display_name":"Ligue Contre le Cancer","ror":"https://ror.org/00rkrv905"},{"id":"https://openalex.org/F4320322890","display_name":"Minist\u00e8re de l'Enseignement Sup\u00e9rieur et de la Recherche","ror":"https://ror.org/03sjk9a61"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":49,"referenced_works":["https://openalex.org/W77471785","https://openalex.org/W1523468597","https://openalex.org/W1545053264","https://openalex.org/W1565148344","https://openalex.org/W1570743730","https://openalex.org/W1595397037","https://openalex.org/W1634220494","https://openalex.org/W1658616513","https://openalex.org/W1963964753","https://openalex.org/W1965041925","https://openalex.org/W1969284241","https://openalex.org/W1977644244","https://openalex.org/W1978193307","https://openalex.org/W1978492782","https://openalex.org/W1981531462","https://openalex.org/W1986461496","https://openalex.org/W1993449698","https://openalex.org/W1994208013","https://openalex.org/W1998760926","https://openalex.org/W2008161863","https://openalex.org/W2021260015","https://openalex.org/W2022589671","https://openalex.org/W2022770236","https://openalex.org/W2023218716","https://openalex.org/W2024106968","https://openalex.org/W2038237125","https://openalex.org/W2041631180","https://openalex.org/W2047231993","https://openalex.org/W2047588262","https://openalex.org/W2065410217","https://openalex.org/W2075468442","https://openalex.org/W2087792530","https://openalex.org/W2091358289","https://openalex.org/W2091423973","https://openalex.org/W2093847817","https://openalex.org/W2096044777","https://openalex.org/W2096273281","https://openalex.org/W2103826752","https://openalex.org/W2105700771","https://openalex.org/W2124257931","https://openalex.org/W2133817674","https://openalex.org/W2152210401","https://openalex.org/W2164029045","https://openalex.org/W2165308436","https://openalex.org/W2166201304","https://openalex.org/W2167490100","https://openalex.org/W2314659450","https://openalex.org/W2316467830","https://openalex.org/W4248474603"],"related_works":["https://openalex.org/W2166201304","https://openalex.org/W2038237125","https://openalex.org/W2068296497","https://openalex.org/W579057310","https://openalex.org/W2018146992","https://openalex.org/W1970126428","https://openalex.org/W2055105276","https://openalex.org/W2523078120","https://openalex.org/W1895238972","https://openalex.org/W2071168981"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":13},{"year":2012,"cited_by_count":11}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}